4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-21-015786
Director sold 4,720 shares at $2.97 ($14,018)
- Director acquired 24,720 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Russell Angus C. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-29 | Exercise or conversion : show line 1 in the form | +24,720 | $2.20 | $54,384 | 92,220 | D |
| 2021-06-29 | Sale : show line 2 in the form | −4,720 | $2.97 | $14,018 | 87,500 | D |
| Open-market sales · 4,720 sh · avg $2.97 · $14,018 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-29 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −24,720 | 0 | D |
Loading xslF345X03/ownership.xml…